ConductScience.org, home

Paper10898685

Antimycobacterial activities of novel levofloxacin analogues.

Kawakami K and 5 others. Antimicrob Agents Chemother, 2000. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antimycobacterial activities of novel levofloxacin analogues. Papers, record 10898685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10898685

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antimycobacterial activities of novel levofloxacin analogues.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2000
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2021-05-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kawakami KK
2Namba KK
3Tanaka MM
4Matsuhashi NN
5Sato KK
6Takemura MM

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
LevofloxacinMajor topic
Mycobacterium aviumMajor topic
Mycobacterium tuberculosisMajor topic
OfloxacinMajor topic
Humans
Microbial Sensitivity Tests
Structure-Activity Relationship

Source PubMed

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12,183,714Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2183714PubMed
22,334,166Influence of N substitution on antimycobacterial activity of ciprofloxacin.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2334166PubMed
31,952,872In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1952872PubMed
41,660,089[Antimycobacterial activities of a new quinolone, sparfloxacin].Kekkaku1991https://conductscience.org/library/papers/1660089PubMed
51,727,901Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States.J Infect Dis1992https://conductscience.org/library/papers/1727901PubMed
61,771,676Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.Tubercle1991https://conductscience.org/library/papers/1771676PubMed
71,663,283In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.Tubercle1991https://conductscience.org/library/papers/1663283PubMed
81,600,578Tuberculosis: a global overview of the situation today.Bull World Health Organ1992https://conductscience.org/library/papers/1600578PubMed
91,296,597Multidrug-resistant tuberculosis.Ann Intern Med1992https://conductscience.org/library/papers/1296597PubMed
108,392,307Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8392307PubMed
118,350,889Treatment of multidrug-resistant tuberculosis.N Engl J Med1993https://conductscience.org/library/papers/8350889PubMed
128,230,135Fluorocyclopropyl quinolones. 1. Synthesis and structure-activity relationships of 1-(2-fluorocyclopropyl)-3-pyridonecarboxylic acid antibacterial agents.J Med Chem1993https://conductscience.org/library/papers/8230135PubMed
138,239,587Anti-Mycobacterium avium activity of quinolones: in vitro activities.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239587PubMed
148,239,588Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239588PubMed
158,046,808Epidemiology of tuberculosis in the United States, 1985 through 1992.JAMA1994https://conductscience.org/library/papers/8046808PubMed
168,067,756Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8067756PubMed
177,944,836Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.Arch Intern Med1994https://conductscience.org/library/papers/7944836PubMed
187,829,409In-vitro activity of quinolones and macrolides against mycobacteria.J Antimicrob Chemother1994https://conductscience.org/library/papers/7829409PubMed
197,695,276In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7695276PubMed
207,778,959National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome.Arch Intern Med1995https://conductscience.org/library/papers/7778959PubMed

See all 33 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40,423,347Secondary Metabolites from a New Antibiotic-Producing Endophytic Streptomyces Isolate Inhibited Pathogenic and Multidrug-Resistant Mycobacterium tuberculosis Strains.Trop Med Infect Dis2025https://conductscience.org/library/papers/40423347PubMed
12,384,378Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12384378PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10898685

GET https://conductscience.org/api/papers/v1/10898685/references?page=2